# A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

> **NCT00532090** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 110 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** RG4733
- **DRUG:** RG4733
- **DRUG:** RG4733

## Key facts

- **NCT ID:** NCT00532090
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532090, "A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00532090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*